Literature DB >> 19229963

Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle.

Stina Salomonsson1, Cecilia Grundtman, Shi-Jin Zhang, Johanna T Lanner, Charles Li, Abram Katz, Lucy R Wedderburn, Kanneboyina Nagaraju, Ingrid E Lundberg, Håkan Westerblad.   

Abstract

Expression of major histocompatibility complex (MHC) class I in skeletal muscle fibers is an early and consistent finding in inflammatory myopathies. To test if MHC class I has a primary role in muscle impairment, we used transgenic mice with inducible overexpression of MHC class I in their skeletal muscle cells. Contractile function was studied in isolated extensor digitorum longus (EDL, fast-twitch) and soleus (slow-twitch) muscles. We found that EDL was smaller, whereas soleus muscle was slightly larger. Both muscles generated less absolute force in myopathic compared with control mice; however, when force was expressed per cross-sectional area, only soleus muscle generated less force. Inflammation was markedly increased, but no changes were found in the activities of key mitochondrial and glycogenolytic enzymes in myopathic mice. The induction of MHC class I results in muscle atrophy and an intrinsic decrease in force-generation capacity. These observations may have important implications for our understanding of the pathophysiological processes of muscle weakness seen in inflammatory myopathies. Muscle Nerve, 2008.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19229963      PMCID: PMC2667561          DOI: 10.1002/mus.21129

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  37 in total

1.  Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies.

Authors:  K Nagaraju; N Raben; L Loeffler; T Parker; P J Rochon; E Lee; C Danning; R Wada; C Thompson; G Bahtiyar; J Craft; R Hooft Van Huijsduijnen; P Plotz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Temporal alterations of immunohistochemical findings in polymyositis.

Authors:  Y Tajima; F Moriwaka; K Tashiro
Journal:  Intern Med       Date:  1994-05       Impact factor: 1.271

3.  Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis.

Authors:  P Nyberg; A L Wikman; I Nennesmo; I Lundberg
Journal:  J Rheumatol       Date:  2000-04       Impact factor: 4.666

4.  Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue.

Authors:  Pernilla Englund; Inger Nennesmo; Lars Klareskog; Ingrid E Lundberg
Journal:  Arthritis Rheum       Date:  2002-04

5.  Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.

Authors:  P Englund; E Lindroos; I Nennesmo; L Klareskog; I E Lundberg
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

6.  Expression of lymphocyte, macrophage and class I and II major histocompatibility complex antigens in normal human dorsal root ganglia.

Authors:  F Graus; E Campo; F Cruz-Sanchez; T Ribalta; A Palacin
Journal:  J Neurol Sci       Date:  1990-09       Impact factor: 3.181

7.  MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies.

Authors:  E Bartoccioni; S Gallucci; F Scuderi; E Ricci; S Servidei; A Broccolini; P Tonali
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

8.  Sepsis-induced changes in protein synthesis: differential effects on fast- and slow-twitch muscles.

Authors:  T C Vary; S R Kimball
Journal:  Am J Physiol       Date:  1992-06

9.  Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments.

Authors:  Michael B Reid; Jan Lännergren; Håkan Westerblad
Journal:  Am J Respir Crit Care Med       Date:  2002-08-15       Impact factor: 21.405

10.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  11 in total

1.  The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy.

Authors:  William Coley; Sree Rayavarapu; Gouri S Pandey; Richard L Sabina; Jack H Van der Meulen; Beryl Ampong; Robert L Wortmann; Rashmi Rawat; Kanneboyina Nagaraju
Journal:  Arthritis Rheum       Date:  2012-11

2.  Increased levels of HSPA5 in the serum of patients with inflammatory myopathies--preliminary findings.

Authors:  Fei Xiao; Jia-Ze Tan; Xiao-Yan Xu; Xue-Feng Wang
Journal:  Clin Rheumatol       Date:  2015-03-10       Impact factor: 2.980

Review 3.  Pathogenesis, classification and treatment of inflammatory myopathies.

Authors:  Mei Zong; Ingrid E Lundberg
Journal:  Nat Rev Rheumatol       Date:  2011-04-05       Impact factor: 20.543

4.  HMGB1 expression and muscle regeneration in idiopathic inflammatory myopathies and degenerative joint diseases.

Authors:  Karolina Cseri; János Vincze; Julianna Cseri; János Fodor; Zoltán Csernátony; László Csernoch; Katalin Dankó
Journal:  J Muscle Res Cell Motil       Date:  2015-03-12       Impact factor: 2.698

5.  A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies.

Authors:  Neil Martin; Petra Krol; Sally Smith; Kevin Murray; Clarissa A Pilkington; Joyce E Davidson; Lucy R Wedderburn
Journal:  Rheumatology (Oxford)       Date:  2010-09-07       Impact factor: 7.580

6.  Isometric and eccentric force generation assessment of skeletal muscles isolated from murine models of muscular dystrophies.

Authors:  Catherine Moorwood; Min Liu; Zuozhen Tian; Elisabeth R Barton
Journal:  J Vis Exp       Date:  2013-01-31       Impact factor: 1.355

Review 7.  Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.

Authors:  Lucy R Wedderburn; Lisa G Rider
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-10       Impact factor: 4.098

Review 8.  Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies.

Authors:  William Coley; Sree Rayavarapu; Kanneboyina Nagaraju
Journal:  Arthritis Res Ther       Date:  2012-04-27       Impact factor: 5.156

9.  Daily supplementation of D-ribose shows no therapeutic benefits in the MHC-I transgenic mouse model of inflammatory myositis.

Authors:  William Coley; Sree Rayavarapu; Jack H van der Meulen; Ayyappa S Duba; Kanneboyina Nagaraju
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

Review 10.  Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.

Authors:  Thorsten Hornung; Joerg Wenzel
Journal:  Drugs       Date:  2014-06       Impact factor: 11.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.